Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Short-term Investments (2022 - 2025)

LifeStance Health (LFST) has disclosed Short-term Investments for 4 consecutive years, with $489000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Short-term Investments fell 86.36% to $489000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $489000.0, a 86.36% decrease, with the full-year FY2024 number at $1.3 million, down 56.6% from a year prior.
  • Short-term Investments was $489000.0 for Q2 2025 at LifeStance Health, down from $847000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $62.6 million in Q2 2023 to a low of $489000.0 in Q2 2025.
  • A 4-year average of $9.0 million and a median of $3.7 million in 2024 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: skyrocketed 37.3% in 2023, then plummeted 94.28% in 2024.
  • LifeStance Health's Short-term Investments stood at $4.4 million in 2022, then tumbled by 33.78% to $2.9 million in 2023, then crashed by 56.6% to $1.3 million in 2024, then plummeted by 61.56% to $489000.0 in 2025.
  • Per Business Quant, the three most recent readings for LFST's Short-term Investments are $489000.0 (Q2 2025), $847000.0 (Q1 2025), and $1.3 million (Q4 2024).